Recent policies reflect China’s goal of promoting patients’ access to innovative drugs. Noteworthy policy items include:

  • State Council releases 2019 Work Tasks to Deepen Healthcare Reform
  • Center for Drug Evaluation releases the first real-world evidence application policy in China for public comment
  • National Health Commission initiates pilot programs to develop hospital alliances and hospital township alliances

The latest issue could be downloaded Here

Leave a comment